Kensey Nash Corporation, a medical device company, engages in the field of regenerative medicine products and technologies to help repair damaged or diseased tissues. The company involves in designing, developing, manufacturing, and processing proprietary medical devices, including resorbable biomaterial products, such as synthetic polymers and collagen. It provides various orthopaedic market products comprising soft tissue and bone fixation products for the fixation and repair of musculoskeletal tissues; and bone void fillers and scaffolds. The company also offers cardiovascular market products that include original Angio-Seal device, a vascular closure device; general surgery market produc...
735 Pennsylvania Drive
Exton, PA 19341
Founded in 1984
Kensey Nash Corporation Announces Amendments to its Bylaws; Announces Board Changes
Jun 25 12
On May 2, 2012, Kensey Nash Corporation entered into an agreement and plan of merger with Koninklijke DSM N.V. and Biomedical Acquisition Corporation. Pursuant to the terms and subject to the conditions of the merger agreement, at 3:00 p.m. ET on June 22, 2012, Biomedical Acquisition Corporation filed a certificate of merger with the Secretary of State of the State of Delaware. Pursuant to the certificate of merger, Biomedical Acquisition Corporation merged with and into Kensey Nash, effective as of 11:59 p.m. ET on June 22, 2012 (Effective Time), in accordance with the short-form merger provisions available under Delaware law, which allow the completion of the merger without a vote or meeting of stockholders of Kensey Nash. Also pursuant to the merger agreement, at the effective time, Kensey Nash's bylaws were amended and restated in their entirety to be identical to the bylaws of Biomedical Acquisition Corporation, as in effect immediately prior to the effective time, except that the name of the company set forth therein is Kensey Nash Corporation.
Effective as of the effective time, each of Joseph W. Kaufmann, Douglas G. Evans, P.E., C. McCollister Evarts, M.D., Robert J. Bobb, Donald E. Morel, Jr., Ph.D., Walter R. Maupay, Jr. and Lisa D. Earnhardt no longer serve on the Board of Directors of Kensey Nash nor any committees of the Board on which they served. Pursuant to the merger agreement, Chistophe Dardel and Hugh C. Welsh became the sole directors of Kensey Nash as of the effective time.
Kensey Nash Corporation(NasdaqGM:KNSY) dropped from Russell 2000 Index
Jun 25 12
Kensey Nash Corporation will be removed from Russell 2000 Index.
Kensey Nash Corporation(NasdaqGM:KNSY) dropped from Russell 3000 Index
Jun 25 12
Kensey Nash Corporationwill be removed from Russell 3000 Index.